(PR-inside.com) PARIS -- (Marketwire) -- 12/13/11 -- Mauna Kea Technologies (EURONEXT PARIS: MKEA), the leader in the endomicroscopy market, announced today the publication of a new study on colorectal cancer in a leading medical journal, Gastrointestinal Endoscopy (GIE). The study results underline the value of Cellvizio®'s probe-based confocal laser endomicroscopy (pCLE) technology in the detection of residual neoplasia after colorectal endoscopic mucosal resection (EMR)."The study adds to the growing body of clinical evidence demonstrating once again, the value of Cellvizio as an advanced imaging system which facilitates real-time diagnosis, follow-up and treatment," said Dr. Emmanuel Coron, Department of Gastroenterology and ..

More...